Obesity Medications
Definition of Obesity: More than half of the U.S. population is overweight. But being obese is different from being overweight. An individual is considered obese when weight is 20% (25% in women) or more over the maximum desirable for their height. When an adult is more than 100 pounds overweight, it is considered morbid obesity.
Obesity is also defined as a BMI (body mass index) over 30 kg/m2. Patients with a BMI between 25 and 29.9 are considered overweight, but not obese. See also diet and calories.
See also: Weight Loss
Drugs associated with Obesity The following drugs and medications are in some way related to, or used in the treatment of Obesity. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Adipex-P (Pro , More... ) generic name: phentermine class: anorexiants , CNS stimulants 3 review(s) Rate It! 8.8
Alli (More... ) generic name: orlistat class: peripherally acting antiobesity agents 8 review(s) Rate It! 8.0
Aplenzin (More... ) generic name: bupropion class: miscellaneous antidepressants , norepinephrine-dopamine reuptake inhibitors 0 review(s) Not rated - Be the first Bontril SR (More... ) generic name: phendimetrazine class: anorexiants , CNS stimulants 11 review(s) Rate It! 8.6
Budeprion (More... ) generic name: bupropion class: miscellaneous antidepressants , norepinephrine-dopamine reuptake inhibitors 0 review(s) Not rated - Be the first Budeprion SR (More... ) generic name: bupropion class: miscellaneous antidepressants , norepinephrine-dopamine reuptake inhibitors 0 review(s) Not rated - Be the first Budeprion XL (More... ) generic name: bupropion class: miscellaneous antidepressants , norepinephrine-dopamine reuptake inhibitors 0 review(s) Not rated - Be the first Desoxyn (Pro , More... ) generic name: methamphetamine class: anorexiants , CNS stimulants 0 review(s) Not rated - Be the first Didrex (Pro , More... ) generic name: benzphetamine class: anorexiants , CNS stimulants 1 review(s) Rate It! 6.3
Meridia (Pro , More... ) generic name: sibutramine class: anorexiants 36 review(s) Rate It! 7.9
Pristiq (More... ) generic name: desvenlafaxine class: serotonin-norepinephrine reuptake inhibitors 2 review(s) Rate It! 8.0
Tagamet (More... ) generic name: cimetidine class: H2 antagonists 0 review(s) Not rated - Be the first Tenuate (More... ) generic name: diethylpropion class: anorexiants , CNS stimulants 9 review(s) Rate It! 9.8
Tenuate Dospan (More... ) generic name: diethylpropion class: anorexiants , CNS stimulants 2 review(s) Rate It! 6.8
Topamax (Pro , More... ) generic name: topiramate class: carbonic anhydrase inhibitor anticonvulsants 4 review(s) Rate It! 6.5
Wellbutrin (Pro , More... ) generic name: bupropion class: miscellaneous antidepressants , norepinephrine-dopamine reuptake inhibitors 0 review(s) Not rated - Be the first Wellbutrin SR (More... ) generic name: bupropion class: miscellaneous antidepressants , norepinephrine-dopamine reuptake inhibitors 1 review(s) Rate It! 9.0
Wellbutrin XL (More... ) generic name: bupropion class: miscellaneous antidepressants , norepinephrine-dopamine reuptake inhibitors 0 review(s) Not rated - Be the first Xenical (Pro , More... ) generic name: orlistat class: peripherally acting antiobesity agents 11 review(s) Rate It! 7.9
Zantryl (More... ) generic name: phentermine class: anorexiants , CNS stimulants 1 review(s) Rate It! 10
20 most popular shown. Show all 43...
See also... Obesity Medications in the Pipeline Zimulti (rimonabant)
November 6, 2008 - Sanofi-aventis to Discontinue all Clinical Trials with rimonabant November 14, 2007 - Rimonabant - Regulatory Update in Europe July 19, 2007 - Committee for Medicinal Products for Human Use Post-authorisation
Summary of Positive Opinion for Acomplia/Zimulti June 29, 2007 - Rimonabant Regulatory Update in the United States June 14, 2007 - Weight Loss Drug Rimonabant Can Cause Serious Physical and
Psychological Harm and Birth Defects, Public Citizen Tells FDA June 13, 2007 - FDA Advisory Committee Did Not Recommend Approval of Rimonabant
(Zimulti) for Use in Obese and Overweight Patients With Associated
Risks Factors March 26, 2007 - Rimonabant USA: Update March 26, 2007 - Sanofi-aventis Acknowledges FDA Announcement of an Advisory Committee Meeting for rimonabant February 12, 2007 - Rimonabant USA: Update December 8, 2006 - Rimonabant Update in the United States February 17, 2006 - Sanofi-aventis Received from the FDA an Approvable Letter for Rimonabant for Weight Management and a Non Approvable Letter for Smoking Cessation June 23, 2005 - Rimonabant Accepted for Filing By the FDA Latest Obesity Blog Post More Can Be Done to Slow Obesity's Toll on Health: Experts
View all Obesity blog
Obesity Support Group Questions Go to the Obesity support group Obesity questions
Ask a Question about Obesity:
Learn more about Obesity Medical encyclopedia results for:
Browse drugs by condition:
